Addressing the Growing Need for HD Specialists
The global shortage of neurologists represents a growing challenge for the delivery of care for individuals with neurodegenerative diseases, including Huntington’s disease (HD). This workforce shortage is multifactorial, driven by an aging population, increasing prevalence of age-related neurological disorders such as Parkinson’s disease and Alzheimer’s disease, and an insufficient number of specialists entering the field.
Recruitment into neurology is further challenged by neurophobia, an inherent nervousness or fear of neurology among medical students due to the complexity of neuroanatomy and neuroscience. This is compounded by limited clinical exposure to individuals living with HD and other rare neurological conditions. As disease-modifying therapies become available, demand for specialist HD care is expected to increase substantially as more individuals living with, or at risk of, HD seek diagnosis, treatment, and ongoing management. This growing gap between workforce capacity and patient need highlights the importance of expanding education and training opportunities in HD care, and the Huntington Study Group is committed to addressing this challenge.
A key strategy is to engage learners earlier in their medical education. Providing HD-specific education during undergraduate and early postgraduate training may reduce neurophobia, increase confidence in managing neurological conditions and encourage greater interest in pursuing careers in neurology and more specifically, HD care. Early exposure will be essential in developing a future workforce equipped to meet the increasing demand for specialized HD services.
ENGAGE-HD: Building Knowledge and Interest in HD Care
ENGAGE-HD is an annual one-day educational course designed for clinicians and clinician-scientists-in-training who are committed to improving care for individuals and families affected by HD. The program provides comprehensive education on the motor and non-motor manifestations of HD, genetic testing, current approaches to clinical management and emerging research through expert-led lectures delivered by internationally recognized HD clinicians and scientists.
It is directed by clinician-researchers Dr. Erin Furr Stimming, Dr. Jee Bang, and Dr. Jody Corey-Bloom.
Importantly, ENGAGE-HD incorporates both scientific and lived experience perspectives. During the in-person sessions, participants have the opportunity to interact with an individual living with HD and their care partner, gaining valuable insight into the experiences of families affected by the disease. The program also includes discussions with HD experts about careers in HD care, providing trainees with a greater understanding of opportunities within the field. Participants who complete the program receive a certificate recognizing their engagement in HD education.
Previous evaluations of ENGAGE-HD have demonstrated positive educational outcomes among attendees. Participants reported improved knowledge of HD research, increased confidence in understanding the motor and non-motor symptoms of HD and greater comfort with the diagnostic process. Importantly, feedback also indicated that participation in the program increased interest in pursuing a career in HD, highlighting the potential of targeted educational initiatives to strengthen the future HD workforce.
Developing Future HD Leaders Through HD-PACT
Beyond its educational objectives, ENGAGE-HD serves as a key pipeline into the Huntington’s Disease Professional Advancement & Commitment Track (HD-PACT) Fellowship. The HD-PACT Fellowship is a one-year, funded clinical and research fellowship that provides approximately $92,000 in support for trainees.
Developed through a collaborative partnership between CHDI, the Huntington Study Group (HSG), the Huntington’s Disease Foundation (HDF), and the Huntington’s Disease Society of America (HDSA), the program represents a significant investment in the future of HD clinical research and specialised patient care. HD-PACT aims to strengthen the HD workforce by developing the next generation of clinical leaders and expanding access to specialised HD care, particularly in regions where specialist availability remains limited.
Beginning in July 2026, HD-PACT fellows will undertake an intensive one-year training program at leading academic institutions with established expertise in HD care and education. Supported by dedicated salary funding, fellows will receive advanced multidisciplinary clinical training and conduct mentored research spanning therapeutic interventions, clinical care, and longitudinal disease outcomes under the guidance of experienced HD clinicians.
Through this immersive experience, the fellowship aims to equip participants with the skills, knowledge and research expertise needed to become future leaders in HD care and clinical research, driving continued advances in the field.
Introducing the Inaugural HD-PACT Fellowship Cohort
The inaugural cohort of six HD-PACT Fellows represents the first generation of trainees supported through this innovative program. Together, these early-career clinicians bring diverse clinical and research backgrounds, while sharing a commitment to improving outcomes for individuals and families affected by HD. Their training and research interests highlight the breadth of expertise needed to advance the future of HD care.

Eilrayna Gelyana, MD
Dr. Eilrayna Gelyana is a Movement Disorders fellow at Northwestern University with a background in neurobiology and neurology training at Harvard University and Johns Hopkins University. She is committed to advancing multidisciplinary HD care alongside translational research into new therapies.

Elliott Hayden, MD, Ph.D.
Dr. Elliott Hayden is a Movement Disorders fellow at Duke University with a particular interest in improving HD clinical care and access to clinical trials. He will contribute to ongoing HD clinical trials and conduct research using longitudinal data from Enroll-HD.

Jorge Patino, MD
Dr. Jorge Patino is a Movement Disorders fellow at the University of Cincinnati with a strong interest in advancing HD research and care. He aims to investigate motor and non-motor outcomes and their association with brain networks, explore novel therapies, and develop the skills needed to lead future HD care initiatives.

Shirin Sadeghpour, MD
Dr. Shirin Sadeghpour is a Movement Disorders fellow at Rush University Medical Center and is pursuing a Master’s degree in Clinical Research focused on HD. She will study the effects of amantadine on gait ataxia in HD, with the goal of advancing evidence-based approaches to HD management.

Sloan Lynch, MD
Dr. Sloan Lynch is a Movement Disorders fellow at UT Health Sciences Houston. He is focused on patient-centered HD research, including an investigator-initiated study evaluating the impact the gut microbiome, diet and oral health has on HD motor and non-motor symptoms, quality of life while providing holistic multidisciplinary care for individuals living with HD.

Tyler Orem, MD
Dr. Tyler Orem is a Movement Disorders fellow at the University of Colorado with a personal connection to HD that has shaped his commitment to HD care, research, and community engagement. Through this fellowship, he will gain advanced clinical and research training, including involvement in clinical trials and studies examining healthcare utilization in individuals with HD.